Global Inactivated Porcine Parvovirus Vaccine Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Inactivated Porcine Parvovirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Porcine Parvovirus Vaccine.
The Inactivated Porcine Parvovirus Vaccine market size, estimations, and forecasts are provided in terms of output/shipments (M Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Inactivated Porcine Parvovirus Vaccine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inactivated Porcine Parvovirus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inactivated Porcine Parvovirus Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Inactivated Porcine Parvovirus Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Inactivated Porcine Parvovirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
The Inactivated Porcine Parvovirus Vaccine market size, estimations, and forecasts are provided in terms of output/shipments (M Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Inactivated Porcine Parvovirus Vaccine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inactivated Porcine Parvovirus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- Merck Animal Health
- HIPRA
- Zoetis
- Ceva
- Bioveta
- Boehringer Ingelheim
- Harbin Pharmaceutical Group
- Wuhan Keqian Biology
- DHN
- China Animal Husbandy Industry
- Qilu Animal Health Products Factorys
- Shandong HuaHong Biological Engineering
- Shanghai Hile Biological
- Liaoning Yikang Biological
- Jilin Zhengye Biological Product
- <107.0 TCID50/mL
- ?107.0 TCID50/mL
- Sows
- Gilts
- Boars
- North America
- Europe
- China
- Japan
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- China Taiwan
- Southeast Asia
- India
- Latin America
- Mexico
- Brazil
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inactivated Porcine Parvovirus Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Inactivated Porcine Parvovirus Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Inactivated Porcine Parvovirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
1 INACTIVATED PORCINE PARVOVIRUS VACCINE MARKET OVERVIEW
1.1 Product Definition
1.2 Inactivated Porcine Parvovirus Vaccine Segment by Type
1.2.1 Global Inactivated Porcine Parvovirus Vaccine Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 <107.0 TCID50/mL
1.2.3 ?107.0 TCID50/mL
1.3 Inactivated Porcine Parvovirus Vaccine Segment by Application
1.3.1 Global Inactivated Porcine Parvovirus Vaccine Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Sows
1.3.3 Gilts
1.3.4 Boars
1.4 Global Market Growth Prospects
1.4.1 Global Inactivated Porcine Parvovirus Vaccine Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Inactivated Porcine Parvovirus Vaccine Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Inactivated Porcine Parvovirus Vaccine Production Estimates and Forecasts (2018-2029)
1.4.4 Global Inactivated Porcine Parvovirus Vaccine Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 MARKET COMPETITION BY MANUFACTURERS
2.1 Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Manufacturers (2018-2023)
2.2 Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Inactivated Porcine Parvovirus Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Inactivated Porcine Parvovirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Inactivated Porcine Parvovirus Vaccine Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Inactivated Porcine Parvovirus Vaccine, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Inactivated Porcine Parvovirus Vaccine, Product Offered and Application
2.8 Global Key Manufacturers of Inactivated Porcine Parvovirus Vaccine, Date of Enter into This Industry
2.9 Inactivated Porcine Parvovirus Vaccine Market Competitive Situation and Trends
2.9.1 Inactivated Porcine Parvovirus Vaccine Market Concentration Rate
2.9.2 Global 5 and 10 Largest Inactivated Porcine Parvovirus Vaccine Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 INACTIVATED PORCINE PARVOVIRUS VACCINE PRODUCTION BY REGION
3.1 Global Inactivated Porcine Parvovirus Vaccine Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Inactivated Porcine Parvovirus Vaccine Production Value by Region (2018-2029)
3.2.1 Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Inactivated Porcine Parvovirus Vaccine by Region (2024-2029)
3.3 Global Inactivated Porcine Parvovirus Vaccine Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Inactivated Porcine Parvovirus Vaccine Production by Region (2018-2029)
3.4.1 Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Inactivated Porcine Parvovirus Vaccine by Region (2024-2029)
3.5 Global Inactivated Porcine Parvovirus Vaccine Market Price Analysis by Region (2018-2023)
3.6 Global Inactivated Porcine Parvovirus Vaccine Production and Value, Year-over-Year Growth
3.6.1 North America Inactivated Porcine Parvovirus Vaccine Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Inactivated Porcine Parvovirus Vaccine Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Inactivated Porcine Parvovirus Vaccine Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Inactivated Porcine Parvovirus Vaccine Production Value Estimates and Forecasts (2018-2029)
4 INACTIVATED PORCINE PARVOVIRUS VACCINE CONSUMPTION BY REGION
4.1 Global Inactivated Porcine Parvovirus Vaccine Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Inactivated Porcine Parvovirus Vaccine Consumption by Region (2018-2029)
4.2.1 Global Inactivated Porcine Parvovirus Vaccine Consumption by Region (2018-2023)
4.2.2 Global Inactivated Porcine Parvovirus Vaccine Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Inactivated Porcine Parvovirus Vaccine Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Inactivated Porcine Parvovirus Vaccine Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 SEGMENT BY TYPE
5.1 Global Inactivated Porcine Parvovirus Vaccine Production by Type (2018-2029)
5.1.1 Global Inactivated Porcine Parvovirus Vaccine Production by Type (2018-2023)
5.1.2 Global Inactivated Porcine Parvovirus Vaccine Production by Type (2024-2029)
5.1.3 Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Type (2018-2029)
5.2 Global Inactivated Porcine Parvovirus Vaccine Production Value by Type (2018-2029)
5.2.1 Global Inactivated Porcine Parvovirus Vaccine Production Value by Type (2018-2023)
5.2.2 Global Inactivated Porcine Parvovirus Vaccine Production Value by Type (2024-2029)
5.2.3 Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Type (2018-2029)
5.3 Global Inactivated Porcine Parvovirus Vaccine Price by Type (2018-2029)
6 SEGMENT BY APPLICATION
6.1 Global Inactivated Porcine Parvovirus Vaccine Production by Application (2018-2029)
6.1.1 Global Inactivated Porcine Parvovirus Vaccine Production by Application (2018-2023)
6.1.2 Global Inactivated Porcine Parvovirus Vaccine Production by Application (2024-2029)
6.1.3 Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Application (2018-2029)
6.2 Global Inactivated Porcine Parvovirus Vaccine Production Value by Application (2018-2029)
6.2.1 Global Inactivated Porcine Parvovirus Vaccine Production Value by Application (2018-2023)
6.2.2 Global Inactivated Porcine Parvovirus Vaccine Production Value by Application (2024-2029)
6.2.3 Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Application (2018-2029)
6.3 Global Inactivated Porcine Parvovirus Vaccine Price by Application (2018-2029)
7 KEY COMPANIES PROFILED
7.1 Merck Animal Health
7.1.1 Merck Animal Health Inactivated Porcine Parvovirus Vaccine Corporation Information
7.1.2 Merck Animal Health Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.1.3 Merck Animal Health Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Merck Animal Health Main Business and Markets Served
7.1.5 Merck Animal Health Recent Developments/Updates
7.2 HIPRA
7.2.1 HIPRA Inactivated Porcine Parvovirus Vaccine Corporation Information
7.2.2 HIPRA Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.2.3 HIPRA Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.2.4 HIPRA Main Business and Markets Served
7.2.5 HIPRA Recent Developments/Updates
7.3 Zoetis
7.3.1 Zoetis Inactivated Porcine Parvovirus Vaccine Corporation Information
7.3.2 Zoetis Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.3.3 Zoetis Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Zoetis Main Business and Markets Served
7.3.5 Zoetis Recent Developments/Updates
7.4 Ceva
7.4.1 Ceva Inactivated Porcine Parvovirus Vaccine Corporation Information
7.4.2 Ceva Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.4.3 Ceva Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Ceva Main Business and Markets Served
7.4.5 Ceva Recent Developments/Updates
7.5 Bioveta
7.5.1 Bioveta Inactivated Porcine Parvovirus Vaccine Corporation Information
7.5.2 Bioveta Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.5.3 Bioveta Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Bioveta Main Business and Markets Served
7.5.5 Bioveta Recent Developments/Updates
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Corporation Information
7.6.2 Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.6.3 Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Boehringer Ingelheim Main Business and Markets Served
7.6.5 Boehringer Ingelheim Recent Developments/Updates
7.7 Harbin Pharmaceutical Group
7.7.1 Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Corporation Information
7.7.2 Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.7.3 Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Harbin Pharmaceutical Group Main Business and Markets Served
7.7.5 Harbin Pharmaceutical Group Recent Developments/Updates
7.8 Wuhan Keqian Biology
7.8.1 Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Corporation Information
7.8.2 Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.8.3 Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Wuhan Keqian Biology Main Business and Markets Served
7.7.5 Wuhan Keqian Biology Recent Developments/Updates
7.9 DHN
7.9.1 DHN Inactivated Porcine Parvovirus Vaccine Corporation Information
7.9.2 DHN Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.9.3 DHN Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.9.4 DHN Main Business and Markets Served
7.9.5 DHN Recent Developments/Updates
7.10 China Animal Husbandy Industry
7.10.1 China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Corporation Information
7.10.2 China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.10.3 China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.10.4 China Animal Husbandy Industry Main Business and Markets Served
7.10.5 China Animal Husbandy Industry Recent Developments/Updates
7.11 Qilu Animal Health Products Factorys
7.11.1 Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Corporation Information
7.11.2 Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.11.3 Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Qilu Animal Health Products Factorys Main Business and Markets Served
7.11.5 Qilu Animal Health Products Factorys Recent Developments/Updates
7.12 Shandong HuaHong Biological Engineering
7.12.1 Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Corporation Information
7.12.2 Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.12.3 Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Shandong HuaHong Biological Engineering Main Business and Markets Served
7.12.5 Shandong HuaHong Biological Engineering Recent Developments/Updates
7.13 Shanghai Hile Biological
7.13.1 Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Corporation Information
7.13.2 Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.13.3 Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.13.4 Shanghai Hile Biological Main Business and Markets Served
7.13.5 Shanghai Hile Biological Recent Developments/Updates
7.14 Liaoning Yikang Biological
7.14.1 Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Corporation Information
7.14.2 Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.14.3 Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.14.4 Liaoning Yikang Biological Main Business and Markets Served
7.14.5 Liaoning Yikang Biological Recent Developments/Updates
7.15 Jilin Zhengye Biological Product
7.15.1 Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Corporation Information
7.15.2 Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.15.3 Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.15.4 Jilin Zhengye Biological Product Main Business and Markets Served
7.15.5 Jilin Zhengye Biological Product Recent Developments/Updates
8 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Inactivated Porcine Parvovirus Vaccine Industry Chain Analysis
8.2 Inactivated Porcine Parvovirus Vaccine Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Inactivated Porcine Parvovirus Vaccine Production Mode & Process
8.4 Inactivated Porcine Parvovirus Vaccine Sales and Marketing
8.4.1 Inactivated Porcine Parvovirus Vaccine Sales Channels
8.4.2 Inactivated Porcine Parvovirus Vaccine Distributors
8.5 Inactivated Porcine Parvovirus Vaccine Customers
9 INACTIVATED PORCINE PARVOVIRUS VACCINE MARKET DYNAMICS
9.1 Inactivated Porcine Parvovirus Vaccine Industry Trends
9.2 Inactivated Porcine Parvovirus Vaccine Market Drivers
9.3 Inactivated Porcine Parvovirus Vaccine Market Challenges
9.4 Inactivated Porcine Parvovirus Vaccine Market Restraints
10 RESEARCH FINDING AND CONCLUSION
11 METHODOLOGY AND DATA SOURCE
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
1.1 Product Definition
1.2 Inactivated Porcine Parvovirus Vaccine Segment by Type
1.2.1 Global Inactivated Porcine Parvovirus Vaccine Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 <107.0 TCID50/mL
1.2.3 ?107.0 TCID50/mL
1.3 Inactivated Porcine Parvovirus Vaccine Segment by Application
1.3.1 Global Inactivated Porcine Parvovirus Vaccine Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Sows
1.3.3 Gilts
1.3.4 Boars
1.4 Global Market Growth Prospects
1.4.1 Global Inactivated Porcine Parvovirus Vaccine Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Inactivated Porcine Parvovirus Vaccine Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Inactivated Porcine Parvovirus Vaccine Production Estimates and Forecasts (2018-2029)
1.4.4 Global Inactivated Porcine Parvovirus Vaccine Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 MARKET COMPETITION BY MANUFACTURERS
2.1 Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Manufacturers (2018-2023)
2.2 Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Inactivated Porcine Parvovirus Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Inactivated Porcine Parvovirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Inactivated Porcine Parvovirus Vaccine Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Inactivated Porcine Parvovirus Vaccine, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Inactivated Porcine Parvovirus Vaccine, Product Offered and Application
2.8 Global Key Manufacturers of Inactivated Porcine Parvovirus Vaccine, Date of Enter into This Industry
2.9 Inactivated Porcine Parvovirus Vaccine Market Competitive Situation and Trends
2.9.1 Inactivated Porcine Parvovirus Vaccine Market Concentration Rate
2.9.2 Global 5 and 10 Largest Inactivated Porcine Parvovirus Vaccine Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 INACTIVATED PORCINE PARVOVIRUS VACCINE PRODUCTION BY REGION
3.1 Global Inactivated Porcine Parvovirus Vaccine Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Inactivated Porcine Parvovirus Vaccine Production Value by Region (2018-2029)
3.2.1 Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Inactivated Porcine Parvovirus Vaccine by Region (2024-2029)
3.3 Global Inactivated Porcine Parvovirus Vaccine Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Inactivated Porcine Parvovirus Vaccine Production by Region (2018-2029)
3.4.1 Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Inactivated Porcine Parvovirus Vaccine by Region (2024-2029)
3.5 Global Inactivated Porcine Parvovirus Vaccine Market Price Analysis by Region (2018-2023)
3.6 Global Inactivated Porcine Parvovirus Vaccine Production and Value, Year-over-Year Growth
3.6.1 North America Inactivated Porcine Parvovirus Vaccine Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Inactivated Porcine Parvovirus Vaccine Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Inactivated Porcine Parvovirus Vaccine Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Inactivated Porcine Parvovirus Vaccine Production Value Estimates and Forecasts (2018-2029)
4 INACTIVATED PORCINE PARVOVIRUS VACCINE CONSUMPTION BY REGION
4.1 Global Inactivated Porcine Parvovirus Vaccine Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Inactivated Porcine Parvovirus Vaccine Consumption by Region (2018-2029)
4.2.1 Global Inactivated Porcine Parvovirus Vaccine Consumption by Region (2018-2023)
4.2.2 Global Inactivated Porcine Parvovirus Vaccine Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Inactivated Porcine Parvovirus Vaccine Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Inactivated Porcine Parvovirus Vaccine Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 SEGMENT BY TYPE
5.1 Global Inactivated Porcine Parvovirus Vaccine Production by Type (2018-2029)
5.1.1 Global Inactivated Porcine Parvovirus Vaccine Production by Type (2018-2023)
5.1.2 Global Inactivated Porcine Parvovirus Vaccine Production by Type (2024-2029)
5.1.3 Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Type (2018-2029)
5.2 Global Inactivated Porcine Parvovirus Vaccine Production Value by Type (2018-2029)
5.2.1 Global Inactivated Porcine Parvovirus Vaccine Production Value by Type (2018-2023)
5.2.2 Global Inactivated Porcine Parvovirus Vaccine Production Value by Type (2024-2029)
5.2.3 Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Type (2018-2029)
5.3 Global Inactivated Porcine Parvovirus Vaccine Price by Type (2018-2029)
6 SEGMENT BY APPLICATION
6.1 Global Inactivated Porcine Parvovirus Vaccine Production by Application (2018-2029)
6.1.1 Global Inactivated Porcine Parvovirus Vaccine Production by Application (2018-2023)
6.1.2 Global Inactivated Porcine Parvovirus Vaccine Production by Application (2024-2029)
6.1.3 Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Application (2018-2029)
6.2 Global Inactivated Porcine Parvovirus Vaccine Production Value by Application (2018-2029)
6.2.1 Global Inactivated Porcine Parvovirus Vaccine Production Value by Application (2018-2023)
6.2.2 Global Inactivated Porcine Parvovirus Vaccine Production Value by Application (2024-2029)
6.2.3 Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Application (2018-2029)
6.3 Global Inactivated Porcine Parvovirus Vaccine Price by Application (2018-2029)
7 KEY COMPANIES PROFILED
7.1 Merck Animal Health
7.1.1 Merck Animal Health Inactivated Porcine Parvovirus Vaccine Corporation Information
7.1.2 Merck Animal Health Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.1.3 Merck Animal Health Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Merck Animal Health Main Business and Markets Served
7.1.5 Merck Animal Health Recent Developments/Updates
7.2 HIPRA
7.2.1 HIPRA Inactivated Porcine Parvovirus Vaccine Corporation Information
7.2.2 HIPRA Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.2.3 HIPRA Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.2.4 HIPRA Main Business and Markets Served
7.2.5 HIPRA Recent Developments/Updates
7.3 Zoetis
7.3.1 Zoetis Inactivated Porcine Parvovirus Vaccine Corporation Information
7.3.2 Zoetis Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.3.3 Zoetis Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Zoetis Main Business and Markets Served
7.3.5 Zoetis Recent Developments/Updates
7.4 Ceva
7.4.1 Ceva Inactivated Porcine Parvovirus Vaccine Corporation Information
7.4.2 Ceva Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.4.3 Ceva Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Ceva Main Business and Markets Served
7.4.5 Ceva Recent Developments/Updates
7.5 Bioveta
7.5.1 Bioveta Inactivated Porcine Parvovirus Vaccine Corporation Information
7.5.2 Bioveta Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.5.3 Bioveta Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Bioveta Main Business and Markets Served
7.5.5 Bioveta Recent Developments/Updates
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Corporation Information
7.6.2 Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.6.3 Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Boehringer Ingelheim Main Business and Markets Served
7.6.5 Boehringer Ingelheim Recent Developments/Updates
7.7 Harbin Pharmaceutical Group
7.7.1 Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Corporation Information
7.7.2 Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.7.3 Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Harbin Pharmaceutical Group Main Business and Markets Served
7.7.5 Harbin Pharmaceutical Group Recent Developments/Updates
7.8 Wuhan Keqian Biology
7.8.1 Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Corporation Information
7.8.2 Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.8.3 Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Wuhan Keqian Biology Main Business and Markets Served
7.7.5 Wuhan Keqian Biology Recent Developments/Updates
7.9 DHN
7.9.1 DHN Inactivated Porcine Parvovirus Vaccine Corporation Information
7.9.2 DHN Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.9.3 DHN Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.9.4 DHN Main Business and Markets Served
7.9.5 DHN Recent Developments/Updates
7.10 China Animal Husbandy Industry
7.10.1 China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Corporation Information
7.10.2 China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.10.3 China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.10.4 China Animal Husbandy Industry Main Business and Markets Served
7.10.5 China Animal Husbandy Industry Recent Developments/Updates
7.11 Qilu Animal Health Products Factorys
7.11.1 Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Corporation Information
7.11.2 Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.11.3 Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Qilu Animal Health Products Factorys Main Business and Markets Served
7.11.5 Qilu Animal Health Products Factorys Recent Developments/Updates
7.12 Shandong HuaHong Biological Engineering
7.12.1 Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Corporation Information
7.12.2 Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.12.3 Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Shandong HuaHong Biological Engineering Main Business and Markets Served
7.12.5 Shandong HuaHong Biological Engineering Recent Developments/Updates
7.13 Shanghai Hile Biological
7.13.1 Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Corporation Information
7.13.2 Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.13.3 Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.13.4 Shanghai Hile Biological Main Business and Markets Served
7.13.5 Shanghai Hile Biological Recent Developments/Updates
7.14 Liaoning Yikang Biological
7.14.1 Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Corporation Information
7.14.2 Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.14.3 Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.14.4 Liaoning Yikang Biological Main Business and Markets Served
7.14.5 Liaoning Yikang Biological Recent Developments/Updates
7.15 Jilin Zhengye Biological Product
7.15.1 Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Corporation Information
7.15.2 Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.15.3 Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2018-2023)
7.15.4 Jilin Zhengye Biological Product Main Business and Markets Served
7.15.5 Jilin Zhengye Biological Product Recent Developments/Updates
8 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Inactivated Porcine Parvovirus Vaccine Industry Chain Analysis
8.2 Inactivated Porcine Parvovirus Vaccine Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Inactivated Porcine Parvovirus Vaccine Production Mode & Process
8.4 Inactivated Porcine Parvovirus Vaccine Sales and Marketing
8.4.1 Inactivated Porcine Parvovirus Vaccine Sales Channels
8.4.2 Inactivated Porcine Parvovirus Vaccine Distributors
8.5 Inactivated Porcine Parvovirus Vaccine Customers
9 INACTIVATED PORCINE PARVOVIRUS VACCINE MARKET DYNAMICS
9.1 Inactivated Porcine Parvovirus Vaccine Industry Trends
9.2 Inactivated Porcine Parvovirus Vaccine Market Drivers
9.3 Inactivated Porcine Parvovirus Vaccine Market Challenges
9.4 Inactivated Porcine Parvovirus Vaccine Market Restraints
10 RESEARCH FINDING AND CONCLUSION
11 METHODOLOGY AND DATA SOURCE
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
LIST OF TABLES
Table 1. Global Inactivated Porcine Parvovirus Vaccine Market Value by Type, (US$ Million) & (2022 VS 2029)
Table 2. Global Inactivated Porcine Parvovirus Vaccine Market Value by Application, (US$ Million) & (2022 VS 2029)
Table 3. Global Inactivated Porcine Parvovirus Vaccine Production Capacity (M Doses) by Manufacturers in 2022
Table 4. Global Inactivated Porcine Parvovirus Vaccine Production by Manufacturers (2018-2023) & (M Doses)
Table 5. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Manufacturers (2018-2023)
Table 6. Global Inactivated Porcine Parvovirus Vaccine Production Value by Manufacturers (2018-2023) & (US$ Million)
Table 7. Global Inactivated Porcine Parvovirus Vaccine Production Value Share by Manufacturers (2018-2023)
Table 8. Global Inactivated Porcine Parvovirus Vaccine Industry Ranking 2021 VS 2022 VS 2023
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Inactivated Porcine Parvovirus Vaccine as of 2022)
Table 10. Global Market Inactivated Porcine Parvovirus Vaccine Average Price by Manufacturers (US$/K Doses) & (2018-2023)
Table 11. Manufacturers Inactivated Porcine Parvovirus Vaccine Production Sites and Area Served
Table 12. Manufacturers Inactivated Porcine Parvovirus Vaccine Product Types
Table 13. Global Inactivated Porcine Parvovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Inactivated Porcine Parvovirus Vaccine Production Value by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 16. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) by Region (2018-2023)
Table 17. Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Region (2018-2023)
Table 18. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) Forecast by Region (2024-2029)
Table 19. Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share Forecast by Region (2024-2029)
Table 20. Global Inactivated Porcine Parvovirus Vaccine Production Comparison by Region: 2018 VS 2022 VS 2029 (M Doses)
Table 21. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) by Region (2018-2023)
Table 22. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Region (2018-2023)
Table 23. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) Forecast by Region (2024-2029)
Table 24. Global Inactivated Porcine Parvovirus Vaccine Production Market Share Forecast by Region (2024-2029)
Table 25. Global Inactivated Porcine Parvovirus Vaccine Market Average Price (US$/K Doses) by Region (2018-2023)
Table 26. Global Inactivated Porcine Parvovirus Vaccine Market Average Price (US$/K Doses) by Region (2024-2029)
Table 27. Global Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Region: 2018 VS 2022 VS 2029 (M Doses)
Table 28. Global Inactivated Porcine Parvovirus Vaccine Consumption by Region (2018-2023) & (M Doses)
Table 29. Global Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Region (2018-2023)
Table 30. Global Inactivated Porcine Parvovirus Vaccine Forecasted Consumption by Region (2024-2029) & (M Doses)
Table 31. Global Inactivated Porcine Parvovirus Vaccine Forecasted Consumption Market Share by Region (2018-2023)
Table 32. North America Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (M Doses)
Table 33. North America Inactivated Porcine Parvovirus Vaccine Consumption by Country (2018-2023) & (M Doses)
Table 34. North America Inactivated Porcine Parvovirus Vaccine Consumption by Country (2024-2029) & (M Doses)
Table 35. Europe Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (M Doses)
Table 36. Europe Inactivated Porcine Parvovirus Vaccine Consumption by Country (2018-2023) & (M Doses)
Table 37. Europe Inactivated Porcine Parvovirus Vaccine Consumption by Country (2024-2029) & (M Doses)
Table 38. Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Region: 2018 VS 2022 VS 2029 (M Doses)
Table 39. Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption by Region (2018-2023) & (M Doses)
Table 40. Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption by Region (2024-2029) & (M Doses)
Table 41. Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (M Doses)
Table 42. Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption by Country (2018-2023) & (M Doses)
Table 43. Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption by Country (2024-2029) & (M Doses)
Table 44. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) by Type (2018-2023)
Table 45. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) by Type (2024-2029)
Table 46. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Type (2018-2023)
Table 47. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Type (2024-2029)
Table 48. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) by Type (2018-2023)
Table 49. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) by Type (2024-2029)
Table 50. Global Inactivated Porcine Parvovirus Vaccine Production Value Share by Type (2018-2023)
Table 51. Global Inactivated Porcine Parvovirus Vaccine Production Value Share by Type (2024-2029)
Table 52. Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses) by Type (2018-2023)
Table 53. Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses) by Type (2024-2029)
Table 54. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) by Application (2018-2023)
Table 55. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) by Application (2024-2029)
Table 56. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Application (2018-2023)
Table 57. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Application (2024-2029)
Table 58. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) by Application (2018-2023)
Table 59. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) by Application (2024-2029)
Table 60. Global Inactivated Porcine Parvovirus Vaccine Production Value Share by Application (2018-2023)
Table 61. Global Inactivated Porcine Parvovirus Vaccine Production Value Share by Application (2024-2029)
Table 62. Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses) by Application (2018-2023)
Table 63. Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses) by Application (2024-2029)
Table 64. Merck Animal Health Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 65. Merck Animal Health Specification and Application
Table 66. Merck Animal Health Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 67. Merck Animal Health Main Business and Markets Served
Table 68. Merck Animal Health Recent Developments/Updates
Table 69. HIPRA Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 70. HIPRA Specification and Application
Table 71. HIPRA Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 72. HIPRA Main Business and Markets Served
Table 73. HIPRA Recent Developments/Updates
Table 74. Zoetis Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 75. Zoetis Specification and Application
Table 76. Zoetis Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 77. Zoetis Main Business and Markets Served
Table 78. Zoetis Recent Developments/Updates
Table 79. Ceva Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 80. Ceva Specification and Application
Table 81. Ceva Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 82. Ceva Main Business and Markets Served
Table 83. Ceva Recent Developments/Updates
Table 84. Bioveta Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 85. Bioveta Specification and Application
Table 86. Bioveta Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 87. Bioveta Main Business and Markets Served
Table 88. Bioveta Recent Developments/Updates
Table 89. Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 90. Boehringer Ingelheim Specification and Application
Table 91. Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 92. Boehringer Ingelheim Main Business and Markets Served
Table 93. Boehringer Ingelheim Recent Developments/Updates
Table 94. Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 95. Harbin Pharmaceutical Group Specification and Application
Table 96. Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 97. Harbin Pharmaceutical Group Main Business and Markets Served
Table 98. Harbin Pharmaceutical Group Recent Developments/Updates
Table 99. Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 100. Wuhan Keqian Biology Specification and Application
Table 101. Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 102. Wuhan Keqian Biology Main Business and Markets Served
Table 103. Wuhan Keqian Biology Recent Developments/Updates
Table 104. DHN Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 105. DHN Specification and Application
Table 106. DHN Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 107. DHN Main Business and Markets Served
Table 108. DHN Recent Developments/Updates
Table 109. China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 110. China Animal Husbandy Industry Specification and Application
Table 111. China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 112. China Animal Husbandy Industry Main Business and Markets Served
Table 113. China Animal Husbandy Industry Recent Developments/Updates
Table 114. Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 115. Qilu Animal Health Products Factorys Specification and Application
Table 116. Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 117. Qilu Animal Health Products Factorys Main Business and Markets Served
Table 118. Qilu Animal Health Products Factorys Recent Developments/Updates
Table 119. Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 120. Shandong HuaHong Biological Engineering Specification and Application
Table 121. Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 122. Shandong HuaHong Biological Engineering Main Business and Markets Served
Table 123. Shandong HuaHong Biological Engineering Recent Developments/Updates
Table 124. Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 125. Shanghai Hile Biological Specification and Application
Table 126. Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 127. Shanghai Hile Biological Main Business and Markets Served
Table 128. Shanghai Hile Biological Recent Developments/Updates
Table 129. Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 130. Liaoning Yikang Biological Specification and Application
Table 131. Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 132. Liaoning Yikang Biological Main Business and Markets Served
Table 133. Liaoning Yikang Biological Recent Developments/Updates
Table 134. Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 135. Jilin Zhengye Biological Product Specification and Application
Table 136. Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 137. Jilin Zhengye Biological Product Main Business and Markets Served
Table 138. Jilin Zhengye Biological Product Recent Developments/Updates
Table 139. Key Raw Materials Lists
Table 140. Raw Materials Key Suppliers Lists
Table 141. Inactivated Porcine Parvovirus Vaccine Distributors List
Table 142. Inactivated Porcine Parvovirus Vaccine Customers List
Table 143. Inactivated Porcine Parvovirus Vaccine Market Trends
Table 144. Inactivated Porcine Parvovirus Vaccine Market Drivers
Table 145. Inactivated Porcine Parvovirus Vaccine Market Challenges
Table 146. Inactivated Porcine Parvovirus Vaccine Market Restraints
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 1. Global Inactivated Porcine Parvovirus Vaccine Market Value by Type, (US$ Million) & (2022 VS 2029)
Table 2. Global Inactivated Porcine Parvovirus Vaccine Market Value by Application, (US$ Million) & (2022 VS 2029)
Table 3. Global Inactivated Porcine Parvovirus Vaccine Production Capacity (M Doses) by Manufacturers in 2022
Table 4. Global Inactivated Porcine Parvovirus Vaccine Production by Manufacturers (2018-2023) & (M Doses)
Table 5. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Manufacturers (2018-2023)
Table 6. Global Inactivated Porcine Parvovirus Vaccine Production Value by Manufacturers (2018-2023) & (US$ Million)
Table 7. Global Inactivated Porcine Parvovirus Vaccine Production Value Share by Manufacturers (2018-2023)
Table 8. Global Inactivated Porcine Parvovirus Vaccine Industry Ranking 2021 VS 2022 VS 2023
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Inactivated Porcine Parvovirus Vaccine as of 2022)
Table 10. Global Market Inactivated Porcine Parvovirus Vaccine Average Price by Manufacturers (US$/K Doses) & (2018-2023)
Table 11. Manufacturers Inactivated Porcine Parvovirus Vaccine Production Sites and Area Served
Table 12. Manufacturers Inactivated Porcine Parvovirus Vaccine Product Types
Table 13. Global Inactivated Porcine Parvovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Inactivated Porcine Parvovirus Vaccine Production Value by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 16. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) by Region (2018-2023)
Table 17. Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Region (2018-2023)
Table 18. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) Forecast by Region (2024-2029)
Table 19. Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share Forecast by Region (2024-2029)
Table 20. Global Inactivated Porcine Parvovirus Vaccine Production Comparison by Region: 2018 VS 2022 VS 2029 (M Doses)
Table 21. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) by Region (2018-2023)
Table 22. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Region (2018-2023)
Table 23. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) Forecast by Region (2024-2029)
Table 24. Global Inactivated Porcine Parvovirus Vaccine Production Market Share Forecast by Region (2024-2029)
Table 25. Global Inactivated Porcine Parvovirus Vaccine Market Average Price (US$/K Doses) by Region (2018-2023)
Table 26. Global Inactivated Porcine Parvovirus Vaccine Market Average Price (US$/K Doses) by Region (2024-2029)
Table 27. Global Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Region: 2018 VS 2022 VS 2029 (M Doses)
Table 28. Global Inactivated Porcine Parvovirus Vaccine Consumption by Region (2018-2023) & (M Doses)
Table 29. Global Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Region (2018-2023)
Table 30. Global Inactivated Porcine Parvovirus Vaccine Forecasted Consumption by Region (2024-2029) & (M Doses)
Table 31. Global Inactivated Porcine Parvovirus Vaccine Forecasted Consumption Market Share by Region (2018-2023)
Table 32. North America Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (M Doses)
Table 33. North America Inactivated Porcine Parvovirus Vaccine Consumption by Country (2018-2023) & (M Doses)
Table 34. North America Inactivated Porcine Parvovirus Vaccine Consumption by Country (2024-2029) & (M Doses)
Table 35. Europe Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (M Doses)
Table 36. Europe Inactivated Porcine Parvovirus Vaccine Consumption by Country (2018-2023) & (M Doses)
Table 37. Europe Inactivated Porcine Parvovirus Vaccine Consumption by Country (2024-2029) & (M Doses)
Table 38. Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Region: 2018 VS 2022 VS 2029 (M Doses)
Table 39. Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption by Region (2018-2023) & (M Doses)
Table 40. Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption by Region (2024-2029) & (M Doses)
Table 41. Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (M Doses)
Table 42. Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption by Country (2018-2023) & (M Doses)
Table 43. Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption by Country (2024-2029) & (M Doses)
Table 44. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) by Type (2018-2023)
Table 45. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) by Type (2024-2029)
Table 46. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Type (2018-2023)
Table 47. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Type (2024-2029)
Table 48. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) by Type (2018-2023)
Table 49. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) by Type (2024-2029)
Table 50. Global Inactivated Porcine Parvovirus Vaccine Production Value Share by Type (2018-2023)
Table 51. Global Inactivated Porcine Parvovirus Vaccine Production Value Share by Type (2024-2029)
Table 52. Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses) by Type (2018-2023)
Table 53. Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses) by Type (2024-2029)
Table 54. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) by Application (2018-2023)
Table 55. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) by Application (2024-2029)
Table 56. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Application (2018-2023)
Table 57. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Application (2024-2029)
Table 58. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) by Application (2018-2023)
Table 59. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) by Application (2024-2029)
Table 60. Global Inactivated Porcine Parvovirus Vaccine Production Value Share by Application (2018-2023)
Table 61. Global Inactivated Porcine Parvovirus Vaccine Production Value Share by Application (2024-2029)
Table 62. Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses) by Application (2018-2023)
Table 63. Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses) by Application (2024-2029)
Table 64. Merck Animal Health Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 65. Merck Animal Health Specification and Application
Table 66. Merck Animal Health Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 67. Merck Animal Health Main Business and Markets Served
Table 68. Merck Animal Health Recent Developments/Updates
Table 69. HIPRA Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 70. HIPRA Specification and Application
Table 71. HIPRA Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 72. HIPRA Main Business and Markets Served
Table 73. HIPRA Recent Developments/Updates
Table 74. Zoetis Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 75. Zoetis Specification and Application
Table 76. Zoetis Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 77. Zoetis Main Business and Markets Served
Table 78. Zoetis Recent Developments/Updates
Table 79. Ceva Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 80. Ceva Specification and Application
Table 81. Ceva Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 82. Ceva Main Business and Markets Served
Table 83. Ceva Recent Developments/Updates
Table 84. Bioveta Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 85. Bioveta Specification and Application
Table 86. Bioveta Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 87. Bioveta Main Business and Markets Served
Table 88. Bioveta Recent Developments/Updates
Table 89. Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 90. Boehringer Ingelheim Specification and Application
Table 91. Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 92. Boehringer Ingelheim Main Business and Markets Served
Table 93. Boehringer Ingelheim Recent Developments/Updates
Table 94. Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 95. Harbin Pharmaceutical Group Specification and Application
Table 96. Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 97. Harbin Pharmaceutical Group Main Business and Markets Served
Table 98. Harbin Pharmaceutical Group Recent Developments/Updates
Table 99. Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 100. Wuhan Keqian Biology Specification and Application
Table 101. Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 102. Wuhan Keqian Biology Main Business and Markets Served
Table 103. Wuhan Keqian Biology Recent Developments/Updates
Table 104. DHN Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 105. DHN Specification and Application
Table 106. DHN Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 107. DHN Main Business and Markets Served
Table 108. DHN Recent Developments/Updates
Table 109. China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 110. China Animal Husbandy Industry Specification and Application
Table 111. China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 112. China Animal Husbandy Industry Main Business and Markets Served
Table 113. China Animal Husbandy Industry Recent Developments/Updates
Table 114. Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 115. Qilu Animal Health Products Factorys Specification and Application
Table 116. Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 117. Qilu Animal Health Products Factorys Main Business and Markets Served
Table 118. Qilu Animal Health Products Factorys Recent Developments/Updates
Table 119. Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 120. Shandong HuaHong Biological Engineering Specification and Application
Table 121. Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 122. Shandong HuaHong Biological Engineering Main Business and Markets Served
Table 123. Shandong HuaHong Biological Engineering Recent Developments/Updates
Table 124. Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 125. Shanghai Hile Biological Specification and Application
Table 126. Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 127. Shanghai Hile Biological Main Business and Markets Served
Table 128. Shanghai Hile Biological Recent Developments/Updates
Table 129. Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 130. Liaoning Yikang Biological Specification and Application
Table 131. Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 132. Liaoning Yikang Biological Main Business and Markets Served
Table 133. Liaoning Yikang Biological Recent Developments/Updates
Table 134. Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Corporation Information
Table 135. Jilin Zhengye Biological Product Specification and Application
Table 136. Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 137. Jilin Zhengye Biological Product Main Business and Markets Served
Table 138. Jilin Zhengye Biological Product Recent Developments/Updates
Table 139. Key Raw Materials Lists
Table 140. Raw Materials Key Suppliers Lists
Table 141. Inactivated Porcine Parvovirus Vaccine Distributors List
Table 142. Inactivated Porcine Parvovirus Vaccine Customers List
Table 143. Inactivated Porcine Parvovirus Vaccine Market Trends
Table 144. Inactivated Porcine Parvovirus Vaccine Market Drivers
Table 145. Inactivated Porcine Parvovirus Vaccine Market Challenges
Table 146. Inactivated Porcine Parvovirus Vaccine Market Restraints
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Inactivated Porcine Parvovirus Vaccine
Figure 2. Global Inactivated Porcine Parvovirus Vaccine Market Value by Type, (US$ Million) & (2022 VS 2029)
Figure 3. Global Inactivated Porcine Parvovirus Vaccine Market Share by Type: 2022 VS 2029
Figure 4. <107.0 TCID50/mL Product Picture
Figure 5. ?107.0 TCID50/mL Product Picture
Figure 6. Global Inactivated Porcine Parvovirus Vaccine Market Value by Application, (US$ Million) & (2022 VS 2029)
Figure 7. Global Inactivated Porcine Parvovirus Vaccine Market Share by Application: 2022 VS 2029
Figure 8. Sows
Figure 9. Gilts
Figure 10. Boars
Figure 11. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) & (2018-2029)
Figure 13. Global Inactivated Porcine Parvovirus Vaccine Production Capacity (M Doses) & (2018-2029)
Figure 14. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) & (2018-2029)
Figure 15. Global Inactivated Porcine Parvovirus Vaccine Average Price (US$/K Doses) & (2018-2029)
Figure 16. Inactivated Porcine Parvovirus Vaccine Report Years Considered
Figure 17. Inactivated Porcine Parvovirus Vaccine Production Share by Manufacturers in 2022
Figure 18. Inactivated Porcine Parvovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. The Global 5 and 10 Largest Players: Market Share by Inactivated Porcine Parvovirus Vaccine Revenue in 2022
Figure 20. Global Inactivated Porcine Parvovirus Vaccine Production Value by Region: 2018 VS 2022 VS 2029 (US$ Million)
Figure 21. Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Region: 2018 VS 2022 VS 2029
Figure 22. Global Inactivated Porcine Parvovirus Vaccine Production Comparison by Region: 2018 VS 2022 VS 2029 (M Doses)
Figure 23. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Region: 2018 VS 2022 VS 2029
Figure 24. North America Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) Growth Rate (2018-2029)
Figure 25. Europe Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) Growth Rate (2018-2029)
Figure 26. China Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) Growth Rate (2018-2029)
Figure 27. Japan Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) Growth Rate (2018-2029)
Figure 28. Global Inactivated Porcine Parvovirus Vaccine Consumption by Region: 2018 VS 2022 VS 2029 (M Doses)
Figure 29. Global Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Region: 2018 VS 2022 VS 2029
Figure 30. North America Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 31. North America Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Country (2018-2029)
Figure 32. Canada Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 33. U.S. Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 34. Europe Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 35. Europe Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Country (2018-2029)
Figure 36. Germany Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 37. France Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 38. U.K. Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 39. Italy Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 40. Russia Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 41. Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 42. Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Regions (2018-2029)
Figure 43. China Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 44. Japan Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 45. South Korea Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 46. China Taiwan Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 47. Southeast Asia Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 48. India Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 49. Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 50. Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Country (2018-2029)
Figure 51. Mexico Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 52. Brazil Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 53. Turkey Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 54. GCC Countries Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 55. Global Production Market Share of Inactivated Porcine Parvovirus Vaccine by Type (2018-2029)
Figure 56. Global Production Value Market Share of Inactivated Porcine Parvovirus Vaccine by Type (2018-2029)
Figure 57. Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses) by Type (2018-2029)
Figure 58. Global Production Market Share of Inactivated Porcine Parvovirus Vaccine by Application (2018-2029)
Figure 59. Global Production Value Market Share of Inactivated Porcine Parvovirus Vaccine by Application (2018-2029)
Figure 60. Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses) by Application (2018-2029)
Figure 61. Inactivated Porcine Parvovirus Vaccine Value Chain
Figure 62. Inactivated Porcine Parvovirus Vaccine Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 1. Product Picture of Inactivated Porcine Parvovirus Vaccine
Figure 2. Global Inactivated Porcine Parvovirus Vaccine Market Value by Type, (US$ Million) & (2022 VS 2029)
Figure 3. Global Inactivated Porcine Parvovirus Vaccine Market Share by Type: 2022 VS 2029
Figure 4. <107.0 TCID50/mL Product Picture
Figure 5. ?107.0 TCID50/mL Product Picture
Figure 6. Global Inactivated Porcine Parvovirus Vaccine Market Value by Application, (US$ Million) & (2022 VS 2029)
Figure 7. Global Inactivated Porcine Parvovirus Vaccine Market Share by Application: 2022 VS 2029
Figure 8. Sows
Figure 9. Gilts
Figure 10. Boars
Figure 11. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) & (2018-2029)
Figure 13. Global Inactivated Porcine Parvovirus Vaccine Production Capacity (M Doses) & (2018-2029)
Figure 14. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) & (2018-2029)
Figure 15. Global Inactivated Porcine Parvovirus Vaccine Average Price (US$/K Doses) & (2018-2029)
Figure 16. Inactivated Porcine Parvovirus Vaccine Report Years Considered
Figure 17. Inactivated Porcine Parvovirus Vaccine Production Share by Manufacturers in 2022
Figure 18. Inactivated Porcine Parvovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. The Global 5 and 10 Largest Players: Market Share by Inactivated Porcine Parvovirus Vaccine Revenue in 2022
Figure 20. Global Inactivated Porcine Parvovirus Vaccine Production Value by Region: 2018 VS 2022 VS 2029 (US$ Million)
Figure 21. Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Region: 2018 VS 2022 VS 2029
Figure 22. Global Inactivated Porcine Parvovirus Vaccine Production Comparison by Region: 2018 VS 2022 VS 2029 (M Doses)
Figure 23. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Region: 2018 VS 2022 VS 2029
Figure 24. North America Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) Growth Rate (2018-2029)
Figure 25. Europe Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) Growth Rate (2018-2029)
Figure 26. China Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) Growth Rate (2018-2029)
Figure 27. Japan Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) Growth Rate (2018-2029)
Figure 28. Global Inactivated Porcine Parvovirus Vaccine Consumption by Region: 2018 VS 2022 VS 2029 (M Doses)
Figure 29. Global Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Region: 2018 VS 2022 VS 2029
Figure 30. North America Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 31. North America Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Country (2018-2029)
Figure 32. Canada Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 33. U.S. Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 34. Europe Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 35. Europe Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Country (2018-2029)
Figure 36. Germany Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 37. France Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 38. U.K. Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 39. Italy Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 40. Russia Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 41. Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 42. Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Regions (2018-2029)
Figure 43. China Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 44. Japan Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 45. South Korea Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 46. China Taiwan Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 47. Southeast Asia Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 48. India Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 49. Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 50. Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Country (2018-2029)
Figure 51. Mexico Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 52. Brazil Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 53. Turkey Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 54. GCC Countries Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2018-2023) & (M Doses)
Figure 55. Global Production Market Share of Inactivated Porcine Parvovirus Vaccine by Type (2018-2029)
Figure 56. Global Production Value Market Share of Inactivated Porcine Parvovirus Vaccine by Type (2018-2029)
Figure 57. Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses) by Type (2018-2029)
Figure 58. Global Production Market Share of Inactivated Porcine Parvovirus Vaccine by Application (2018-2029)
Figure 59. Global Production Value Market Share of Inactivated Porcine Parvovirus Vaccine by Application (2018-2029)
Figure 60. Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses) by Application (2018-2029)
Figure 61. Inactivated Porcine Parvovirus Vaccine Value Chain
Figure 62. Inactivated Porcine Parvovirus Vaccine Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
